Zhishan Weixin Biotechnology

China
Chengdu, Sichuan, China

Company profile

Zhishan Weixin Biotechnology company profile

Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2018-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$296,657
Last funding
Series B / 2025-07-22
Last equity funding
Series B
Investors
12
Lead investors
3

Founders and investors

Lead investors

Loyal Valley CapitalSDIC Venture CapitalZhengxingu Capital

Investors

Delian CapitalLoyal Valley CapitalMorningsidePan-Lin CapitalSDIC Venture Capital